Verano Brianza, Italy

Luigi Preda


Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1992-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Luigi Preda: Innovator in Thrombotic Risk Assessment

Introduction

Luigi Preda is a notable inventor based in Verano Brianza, Italy. He has made significant contributions to the field of medical diagnostics, particularly in assessing thrombotic risk through innovative methods and kits. With a total of 2 patents to his name, Preda's work is instrumental in advancing healthcare solutions.

Latest Patents

One of Luigi Preda's latest patents is a method for determining thrombotic risk in individuals. This invention involves assessing the activity of Protein C and Protein S in plasma samples. The method includes adding specific reagents to induce coagulation and measure the conversion of fibrinogen to fibrin. The results provide an indication of thrombotic risk, which is crucial for patient management. Additionally, he has developed a kit designed to facilitate this testing process, enhancing the practicality of his invention.

Another significant patent focuses on determining the functional activity of protein S in human plasma. This method evaluates the biological activity of protein S by using a substrate formed from plasma deficient in protein S. The evaluation is conducted through a coagulometric test, which is essential for understanding coagulation processes in patients.

Career Highlights

Throughout his career, Luigi Preda has worked with reputable companies such as Instrumentation Laboratory S.p.a. and Instrumentation Laboratory S.r.l. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.

Collaborations

Luigi Preda has collaborated with professionals in his field, including Antonio Lombardi. These partnerships have likely fostered the development of his innovative ideas and patents.

Conclusion

Luigi Preda's contributions to thrombotic risk assessment through his patents demonstrate his commitment to improving medical diagnostics. His innovative methods and kits are valuable assets in the healthcare industry, showcasing the importance of research and development in addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…